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Background: Early detection of neural conductivity changes at the compressed spinal cord is important for
predicting the surgical outcomes of patients with cervical spondylotic myelopathy (CSM). The prognostic value
of median nerve somatosensory evoked potential (SEP) has been proposed previously. The present prospective
study evaluates the use of trial-to-trial variability in SEP as a valuable predictor of neurological recovery after
surgery of CSM.
Methods: A total of 35 CSM patients who underwent surgery with up to 6-month follow-up were recruited in
this study. SEP signals were recorded preoperatively. The single trial SEP was extracted by a newly developed
second-order blind identification method. The postoperative recovery was assessed using the modified Japanese
Orthopaedic Association. The correlation between the latency variability of trial-to-trial SEP and post-operative
recovery ratio was analyzed. The prognostic value of trial-to-trial SEP for CSM was evaluated using a receiver operator
characteristic curve which can accurately reflect the relationship between sensitivity and specificity of a diagnostic
method and represent the accuracy of prognosis.
Results: The correlation coefficient of trial-to-trial latency variability and the 6-month recovery ratio was statistically
significant (r = −0.82, P < 0.01). The trial-to-trial SEP had a higher prognostic accuracy (AUC = 0.928, P < 0.001) with
an optimal prognostic value of 9.25 % compared with averaged SEP when the threshold of recovery ratio was
40 %, and was more sensitive (93.80 %) than the averaged SEP (43.80 %).
Conclusions: These findings indicate that the latency variability of trial-to-trial SEP reflect the recovery ratio of
CSM patients after surgery. It is suggested that the latency variability of trial-to-trial SEP is useful for predicting
the surgical outcomes for patients with CSM, which would be a potential indication of surgical treatment for
CSM to help decision making of surgical planning for CSM patients.
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Cervical spondylotic myelopathy (CSM) is the most
common cause of spinal cord disorder among the elderly
over 55 years old [1, 2]. Surgical decompression is con-
sidered as the most effective treatment for patients with
CSM [3]. However, the accurate prognosis of surgical
outcome is still a problem during clinical treatment
decision making [3–5]. Postoperative outcomes are
affected by multiple prognostic factors [6], making the
clinical outcome of CSM unexpectedly complex, and
generates variability in the prognosis.
Several studies have investigated the prognostic value
of somatosensory evoked potential (SEP) for CSM [7–10].
One previous study demonstrated that preoperative
somatosensory evoked potentials can provide import-
ant information correlated with prognosis [11], and
preoperative SEP showed good correlation with CSM
disability [10, 12].
The latency and amplitude of SEP are two sensitive
parameters reflecting nerve conductivity along the spinal
cord. The abnormal latency by itself is a better predictor
of outcome than is abnormal amplitude by itself [10],
because changes in latency are more sensitive to spinal
cord injury and neurological recovery [8, 13, 14]. Previ-
ous studies employed across-trial ensemble averaging
method of 100 to 500 trials to obtain a measurable SEP
signal [10], since SEP signals are usually accompanied by
noise from movement artifact, other electrophysiological
signals, and environmental electromagnetic activity [15,
16]. A previous paper reported that averaging SEP can-
not detect the time-variant neurological abnormalities
[13], which is supposed to be a main feature in CSM.
The pathological progress of CSM includes demyelin-
ation, axon loss and neuronal apoptosis [17], which are
incomplete damage to the spinal cord. The pathological
changes in CSM lead to the altered or disturbed connec-
tion induced by the alterations to the neural signals and
sources, representing abnormalities of conduction velocity
and dispersion of conduction due to electrophysiological
derangement [18]. With the progress of myelopathy, the
increasing amount of demyelination and axon loss would
lead large variation in single trial SEP latency. Because the
extent of pathological changes is closely correlated with
the prognosis, trial-to-trial latency variability would be a
useful measurement to indicate the prognosis of CSM
treatment. For this reason, it is worthy to evaluate the use-
fulness of cross-trial dynamics of SEP in CSM prognosis.
However, use of ensemble averaging method with a
large number of SEP trials may minimize time-variant
abnormalities of conductivity [15]. To obtain a reliable
estimation of single evoked potential response, several
methods have been developed under poor signal-to-noise
ratio [13, 19–21]. In 1979, Kearney proposed to use Weiner
filtering to the estimate tonic electromyography activityresponses after electrical stimulation of the foot [22]. Re-
sults showed a significant reduction in the number of
averaging, but it did not prove the usefulness in single
trial SEP extraction. It is much more difficult to extract
single-trial SEP than other evoked potentials like
evoked electromyography, visual evoked potentials and
audio evoked potentials. Recently, improved perform-
ance has been reported for blind source separation,
which is a technique that recovers unknown source sig-
nals from mixed and observed data sets [13, 19, 20].
Compared with other blind identification algorithms
for SEP detection, second-order blind identification has
many advantages such as simplicity, reliability, robust-
ness, and applicable Gaussian signals [13, 19, 20]. More
importantly, second-order blind identification is robust
for short serial-signals [23]. Therefore, second-order
blind identification offers a favorable alternative for de-
tecting neural transmission variation [13].
Considering the usefulness of SEP latency variation in
detecting neurophysiological dysfunction [13], the aim of
this study is to evaluate the prognostic value of latency
variability of trial-to-trial SEP in neurological recovery
after surgery of CSM.
Methods
Subjects
A total of 35 patients with CSM (19 men and 16 women),
who underwent cervical surgery between April 2010 and
September 2012 were recruited. The mean age was 60.4 ±
11.2 years (range, 55–70 years) and the mean duration of
symptoms was 43 ± 51 weeks (range, 24–560 weeks). All
patients were followed up postoperatively for 6 months.
These patients had no other neurologic diseases. All pa-
tients provided informed consent, and the procedures
were approved by the Institutional Review Board of the
University of Hong Kong/Hospital Authority Hong Kong
West Cluster.
Clinical assessment
To evaluate the clinical outcome for surgical management
of CSM, the Japanese Orthopaedic Association (JOA)
score was used to assess the pre- and postoperative
clinical condition [10]. The JOA score is a useful tool
to evaluate the severity of neurologic deficits. The
maximum JOA score is 17, including motor dysfunc-
tion of the upper (4 scores) and lower extremities (4
scores), sensory deficits of the limbs (4 scores) and
trunk (2 scores), and sphincter dysfunction (3 scores)
[24]. Low score represents the severity of neurological
deficit [10, 25]. All patients were clinically evaluated
by the JOA score before the operation and at 6 months
postoperatively. Surgical outcome with 6 months
follow-up was evaluated by the recovery ratio and cal-
culated as follows [10, 25]:
Recovery ratio ¼ postoperative JOA score‐preoperative JOA score
17 points‐preoperative JOA score
 100%
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Median nerve SEP were recorded preoperatively to de-
termine diagnosis and prognosis of CSM. During the
SEP test, the patient was asked to lie on a couch in a
warm and semi darkened room.
The median nerve at the wrist was stimulated by constant
current stimulus ranging 10 to 30 mA, with a frequency be-
tween 5.1 and 5.7 Hz and duration of 0.3 ms. The SEP sig-
nals were recorded at Cz´ (2 cm posterior to Cz, 10–20
international system of EEG electrode placement), C3 and
C4 (10–20 international system of EEG electrode place-
ment) and Cv (on the cervical spine over the C2 process)
with the reference electrode at Fz (10–20 international
system of EEG electrode placement). All signals were
recorded with a sampling rate of 5 kHz for each re-
cording channel by an evoked potential recording sys-
tem (YRKJ-A2004; Zhuhai yiruikeji Co., Ltd., Zhu Hai,
China), using 20–2000 Hz bandpass filter and auto-
matic artifact rejection performed. The automatic
artifact rejection was designed to reject the bad trials
with large amplitude after 5 ms of sweep. A continue
SEP of 100 trials was recorded at left and right median
nerve respectively, saved as 2 sets of single trial SEP
data for further processing.Fig. 1 Block diagram of second order blind identification with a reference
input signal, reference signal, output signal and the main processing part o
When the input signal is X (t), the learning demixing matrix A must be adju
constraint relative to the output y (t) according to reference signals R (t), U
estimated output y (t) and the reference R (t), the optimal output y(t) = y* cSomatosensory evoked potential processing
Single trial SEP was determined by second order blind
identification with a reference algorithm [19], which is
developed from the traditional blind source separation
algorithm [21]. In the classical second order blind identifi-
cation, a rotation matrix Vis chose to jointly diagonalize
all of them by minimizing,
X
τ
X
i≠j
V TRτV
 
ij
2 ð1Þ
the sum of the squares of the off-diagonal entries of the
matrix products VTRτV, via an iterative process. Rτ de-
notes a set of time-lagged covariance matrices defined as
Rτ ¼ E x t þ τð Þx tð ÞT
 
; τ≠0 ð2Þ
Users can set a threshold parameter for the angle of
rotation of V. When the angle is smaller than the thresh-
old, the iterative process ends. The final estimate of the
unmixing matrix is:
W ¼ VB ð3Þ
which is used to derive the separated components.
As shown in Fig. 1, the recorded multi-channel SEP
signals X (t) = [x1, x2,…, xM]
T are assumed to be a mix-
ture of source components where A is a M ×N unknownalgorithm to analyze single trial SEP. The framework is presented with
f the second order blind identification with a reference algorithm.
sted by both second order blind identification and the closeness
ntil y (t) = y*is the constraint condition of closeness between the
an be obtained
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output, and R (t) is the reference signal.
X tð Þ ¼ ATS tð Þ ð4Þ
The second order blind identification with a reference
is designed to extract a single desired source and discard
the rests which are irrelevant to the reference signal. In
this study, only the main component in post-tibial nerve
short-latency SEP is of interest, and then the computa-
tional load can be greatly reduced. In this situation, the
goal of this algorithm was to identify a demixing vector
w (one column of the learning demixing matrix W) such
that the output signal is equal to the desired source
signal S (t):
y tð Þ ¼ wTX tð Þ ¼ wTATS tð Þ ¼ S tð Þ ð5Þ
Where S (t) = [s1, s2,…, sN] is a mixtures of N inde-
pendent source signal.
Different from the classical second order blind identifi-
cation, second order blind identification with a reference
needs another objective function to establish the rela-
tionship between y (t) and both equation (1) and R (t).
The first part contrast function is to minimize J (y)
defined as
J yð Þ ¼ −
X
τ
E y tð Þy t−τð ÞT
 2
ð6Þ
The closeness between the estimated output y and the
corresponding reference r is measured by ɛ (y, r), whose
minimum value indicates the optimal output y* of J (y).
A threshold ξ can be used as a constraint condition of
closeness such that
g yð Þ ¼ ε y; rð Þ−ξ≤0 ð7Þ
is satisfied only when y = y*. By incorporating (6) with
(7), second order blind identification with a reference
can be formulated as follows:
minimize J(y) = − ∑τE(y(t)y(t − τ)
T)2
subject to g (y) ≤ 0 and h (y) = 0 (8)
where h(y) = E(yyT) − 1 is included to restrict the output
have unit variance.
By adopting the Lagrange multipliers method for op-
timal solution, the augmented Lagrangian function is
given as
L w; μ; λ; zð Þ ¼ J yð Þ þ μg^ yð Þ þ 1
2
γ g^ yð Þk k2
þλh yð Þ þ 1
2
γ h yð Þk k2
ð9Þ
where μ and λ are Lagrange multipliers for the inequal-
ity constraint and the equality constraint respectively,
and γ is a scalar penalty. z is a slack variable to convert
the inequality constraint into equality constraint.The minimization of (9) with respect to z can be per-
formed explicitly for fixed w as follows:
min
z
L w; μ; λ; zð Þ ¼ min
z2≥0
μ g yð Þ þ z2 þ 1
2
γ g yð Þ þ z2 2
 
ð10Þ
A Newton-like learning algorithm is used to find the
optimal value as [19]
Δw ¼ −η ∂
2L w; μ; λð Þ
∂w2
	 
−1 ∂L w; μ; λð Þ
∂w
ð11Þ
where η is the learning rate. The Lagrange multipliers
μ and λ are updated as
Δμ ¼ max −μ; γg yð Þf g ð12Þ
Δλ ¼ γh yð Þ ð13Þ
Until the error, |J (y) k+1 − J (y) k| is small enough,
otherwise go back to update the vector w by wk + 1 =
wk + Δw. Details of the second order blind identification
algorithm is seen in Additional file 1.
After being processed by the second order blind iden-
tification algorithm, recordings were visually analyzed
for the presence of the main peaks N1-P1, and the mea-
sured parameters of cortical response included peak la-
tency of N1. Single trial SEP were analyzed in 100 SEP
recordings. After the standard deviation of latency was
calculated from results of the 100 recordings, the latency
variability of trial-to-trial SEP was defined as the ratio
between the standard deviation and the mean value,
which was calculated as follows:
Latency variability ¼ standard deviation
mean value
 100%
In each subject, latency variability of trial-to-trial SEP
was calculated in left and right median nerve SEP. In
these two values of latency variability, the lowest vari-
ability was selected for this subject for prognosis
evaluation.
Statistical analysis
Data were presented as the mean ± standard deviation.
The correlation between the trial-to-trial SEP variability
and the surgical outcome was determined using the
Pearson correlation coefficient analyzed with the soft-
ware program SPSS 16.0. Statistical significance was des-
ignated at α = 0.05 using a bilateral test (two-tailed). A
P-value < 0.05 and an absolute correlation coefficient ≥
0.50 were considered a significant linear correlation.
In addition, the receiver operator characteristic curve
was used to evaluate the performance of second order
blind identification with a reference algorithm in predict-
ing the prognosis of CSM. Receiver operator characteristic
Fig. 3 Single trial SEP measured using second order blind
identification with a reference in CSM patients. The 50 single trial
SEP are presented with latency and amplitude values. The above is
the three dimensional map of single-trial SEP in latency-amplitude-
trial number, and the below is the projection on latency-trial number
coordinate. The color presents the values of single-trial SEP amplitude
with a latency between 10 ms to 20 ms
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sitivity and specificity of a diagnostic method compared
with a standard method and can represent the diagnostic
accuracy of the method. The area under the curve (AUC)
of receiver operator characteristic is between 1.0 and 0.5.
Assuming AUC > 0.5 [26], a higher AUC indicates better
diagnostic value of the method as follows: AUC = 0.5–0.7
indicates low accuracy; AUC= 0.7–0.9 indicates certain
accuracy; and an AUC > 0.9 indicates high accuracy [26].
An AUC = 0.5 indicates no diagnostic value; that is, the
diagnostic method does not work. In this study, JOA score
is defined as the standard method and the variability of
trial-to-trial SEP and averaged SEP were compared as
diagnostic methods.
Results
The latency in all 35 patients determined by the ensem-
ble averaging method was 19.25 ± 1.90 ms in mean ±
standard deviation, and the latency variability determined
by second order blind identification with a reference
method was 9.55 ± 2.08 ms. Figure 2 shows a representative
ensemble averaging waveform measuring 50 raw SEP in
one CSM patient and a sample of single-trial SEP. Extracted
by second order blind identification with a reference, a
series of single trial SEP have different latency values,
which demonstrates the latency variability of trial-to-trial
SEP (Fig. 3).
The preoperative JOA score increased from 4 to 14
with a mean value 10.68, and the postoperative JOA
score increased from 7.5 to 17 with a mean value 13.90.
The mean recovery ratio was 41.08 % (ranged from 0 to
100 %). Figure 4 shows the correlation between theFig. 2 Representative ensemble averaging waveform generated from
50 raw SEP and a sample of single-trial SEP. The SEP waveforms are
compared that extracted by ensemble averaging method and second
order blind identification with a reference algorithm. The above signal
is the ensemble averaging waveform, and the below is the single-trial
SEP. They have similar shape within 15 ms and 25 mslatency variability of the trial-to-trial SEP and the recov-
ery ratio. The data points were regularly distributed in the
Cartesian coordinate plane, and the trend line showed a
strong correlation (r = −0.82, P < 0.01), which indicated
that latency variability of the trial-to-trial SEP was corre-
lated to postoperative outcome.
According previous report [27], the recovery ratio of
40 % was considered the diagnostic threshold criteria for
an acceptable good prognosis. The optimal diagnostic
threshold value of latency variability of trial-to-trial SEP
was 9.25 %. When the preoperative latency variability ofFig. 4 Correlation between the latency variability of TTSEP and the
6-month postoperative recovery ratio. The latency variability of TTSEP
and the 6-month postoperative recovery ratio in percentage are
compared using correlation analysis. The red stars are the scattered
recovery ratio and latency variation of TTSEP of 35 patients distributing
regularly, and the green line is the trend line between them. The statistic
correlation coefficient r is −0.82 presenting a significant negative
correlation (P < 0.01)
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ratio was less than 40 %, and when the preoperative la-
tency variability of trial-to-trial SEP was less than
9.25 %, the recovery ratio was greater than 40 %. In aver-
aging SEP, the diagnostic threshold criterion was defined
as delayed latency (18.41 + 2.5*0.71 = 20.19 ms) [10]. In
this group of patients, the sensitivity of prognosis by
trial-to-trial SEP presented 93.80 %, while the sensitivity
by averaging SEP was 43.80 %. Figure 5 illustrates the re-
ceiver operator characteristic curve with a 40 % recovery
ratio as the criterion of good prognosis. The AUC of la-
tency variability of trial-to-trial SEP was 0.928 (P < 0.001),
and the AUC of averaged SEP was 0.640 (P < 0.001), indi-
cating that the latency variability of trial-to-trial SEP had a
higher accuracy for CSM prognosis.
Discussion
This study demonstrates that latency variability of trial-to-
trial SEP is closely correlated with recovery ratio after surgi-
cal management of CSM. In comparison with conventional
averaging SEP, the latency variability of trial-to-trial SEP
presented much higher sensitivity and specificity in predict-
ing surgical outcomes of CSM. This finding suggests that
latency variability of trial-to-trial SEP is able to provide a
precise prognosis of CSM surgery.
The prognosis for neurologic recovery after surgical
treatment of CSM is important in informing both patients
and surgeons of what to expect [28, 29]. The pathologicalFig. 5 Receiver operator characteristic curves for the latency
variability of TTSEP and averaged SEP at a 40 % recovery ratio
threshold. The diagnostic methods of variability of TTSEP and
averaged SEP were compared according to the recovery ratio
with their specificity and sensitivity. Red line is presented latency
variability of TTSEP, green line is averaged SEP, and pink dashed
line is reference line considered the diagnostic criteria with a
threshold 40 %. Bigger area under the curve (AUC) of red line
indicates better diagnostic value of the variability of TTSEP
method for CSM than averaged SEPprogress of CSM includes demyelination, axon loss and
neuronal apoptosis [17], which change the conductivity of
spinal cord. The diagnostic value of SEP in CSM patients
has been reported [7–10, 12], and some studies have sug-
gested that SEP may be useful for predicting the postoper-
ative prognosis in CSM patients [11]. The prognostic
value of SEP abnormalities in CSM patients has not been
systematically studied, particularly the correlation between
SEP variability and the postoperative outcomes in CSM
patients. SEP can reflect the nervous status along a par-
ticular pathway in response to an external stimulus [7].
However, in clinical conditions, SEP signals are usually
flooded by numerous noise signals from the patient and
the environment [15, 20], which makes detection of the
SEP peak difficult and often results in inaccurate measure-
ments. Ensemble averaging is often used to enhance the
signal-to-noise ratio, but it does not allow evaluation of
time-varying associated features that may be more suitable
for dynamic variability analysis [13, 30]. Early detection of
neural conductivity changes at the compressed spinal cord
would be an indication for surgical decision of patients
with CSM.
Bouchard et al. reported that intraoperative SEP
changes are associated with the short-term recovery ra-
tio of CSM, but there is no obvious correlation with the
long-term recovery ratio, which decreases its prognostic
value [12]. In this study, we analyzed the neurological
recovery ratio at 6 months postoperatively. The results
showed a significant correlation between the preopera-
tive trial-to-trial SEP variability and the postoperative
clinical improvement measured by the recovery ratio,
which represents the neurological recovery of CSM
patients. This finding is consistent with that reported by
Matsukado [31] and Hu [10].
Analysis of single trial signals, rather than the across-
trial ensemble averaging signals, can detect changes in
SEP [13], and many investigators have described single
trial signal processing algorithms to improve the evoked
potential signal and better understand the waveform
changes over time [19, 32–35]. The traditional second
order blind identification processed signal requires com-
paratively less time averaging [19]. Constrained second-
order blind identification is a blind source separation
technique based on two orders of blind source separ-
ation to remove the irrelevant signal components [23],
extract the signal components associated with the refer-
ence algorithm, and isolate the desired signal, which
greatly reduces the amount of computation [19]. Re-
cently, second order blind identification has been con-
firmed as one of the best techniques for single trial SEP
detection [19]. In addition, one previous study found
that latency measurements are a more reproducible
and reliable indicator of neurologic deficits, and latency
is a better predictor of clinical outcome [10]. Therefore,
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trial-to-trial SEP to evaluate the utility of the SEP for
predicting the prognosis of CSM patients. To clarify
the correlation between the trial-to-trial SEP latency
variability and postoperative recovery in CSM patients,
we systemically analyzed the relationship between the
latency variability of trial-to-trial SEP and the recovery
ratio of CSM. In addition, the receiver operator character-
istic was used to evaluate the prognostic value of latency
variability of trial-to-trial SEP. The results showed that
when using the single trial SEP extracted by second order
blind identification with a reference, it was not only easier
to identify the peak, but also to obtain the variability in
trial-to-trial SEP. As seen in Fig. 3, the latencies change
between the various trials was apparent.
In the present study, the receiver operator characteristic
curve indicated that the latency variability of trial-to-trial
SEP had a much better precision in prognostic value for
CSM (AUC = 0.928, P < 0.001) than did averaged SEP
(AUC = 0.640, P < 0.001). In a previous study [25], the pre-
cision of prognosis of preoperative JOA score was evalu-
ated by ROC curve as AUC= 0.489, which suggested the
merit of trial-to-trial SEP as a good predicting factor for
prognostics evaluation of CSM.Conclusions
Second order blind identification with a reference can
detect changes in latency of trial-to-trial SEP in patients
with CSM. Furthermore, the variability of the trial-to-
trial SEP signal was significantly correlated with the
neurological recovery ratio measured by the JOA score
and was more sensitive than the averaged SEP. There-
fore, preoperative variability of trial-to-trial SEP may be
more suitable for measuring changes in neurological
function of CSM patients and is likely a better predictor
of postoperative prognosis for CSM patients. Trial-to-trial
SEP may be used to predict the magnitude of clinical im-
provement in patients undergoing surgery for CSM treat-
ment, which is useful for surgical and prognostic planning
for CSM.Additional file
Additional file 1: Single trial SEP extraction algorithm using second
order blind identification with a reference.Abbreviations
CSM: Cervical spondylotic myelopathy; SEP: Somatosensory evoked potential;
TTSEP: Trial-to-trial somatosensory evoked potential; JOA: Japanese
orthopaedic association scoring system; AUC: Area under the curve.Competing interests
The authors declare that they have no competing interests.Authors’ contributions
HC, YH, YW, LP, AC were involved in analysis and interpretation of data, as
well as in drafting and revising the manuscript, PT revised it critically for
important intellectual content. HC, SX, YH made substantial contributions to
conception and design of the study. YW, XL, XX were involved in acquisition
of data. All authors read and approved the final manuscript.
Acknowledgements
This study was supported by National Natural Science Foundation of China
(No. 81301287) and a grant from the Research Grants Council of the Hong
Kong SAR (GRF 767511 M).
Received: 8 December 2014 Accepted: 22 May 2015
References
1. Baptiste D, Fehlings M. Pathophysiology of cervical myelopathy. Spine J.
2006;6(6 Suppl):190S-197S.
2. Liu B, Ma W, Zhu F, Guo CH, Yang WL. Comparison between anterior and
posterior decompression for cervical spondylotic myelopathy: subjective
evaluation and cost analysis. Orthop Surg. 2012;4(1):47–54.
3. McCormick WE, Steinmetz MP, Benzel EC. Cervical spondylotic myelopathy:
make the difficult diagnosis, then refer for surgery. Cleve Clin J Med.
2003;70(10):899–904.
4. Zhang W, Zhang J, Yang J, Xue H, Cao D, Huang H, et al. The role of
magnetic resonance imaging in pretreatment evaluation of early-stage
cervical cancer. Int J Gynecol Cancer. 2014;24(7):1292–8.
5. Li X, Cui JL, Mak KC, Luk KDK, Hu Y: Potential use of diffusion tensor
imaging in level diagnosis of multilevel cervical spondylotic myelopathy.
Spine 2014, 39(10):E615-E622.
6. Ahn JS, Lee JK, Kim BK. Prognostic factors that affect the surgical outcome
of the laminoplasty in cervical spondylotic myelopathy. Clin Orthop Surg.
2010;2(2):98–104.
7. Roh MS, Wilson-Holden TJ, Padberg AM, Park JB, Daniel Riew K. The utility
of somatosensory evoked potential monitoring during cervical spine surgery:
how often does it prompt intervention and affect outcome? Asian spine
journal. 2007;1(1):43–7.
8. Bednarik J, Kadanka Z, Vohánka S, Stejskal L, Vlach O, Schröder R. The value
of somatosensory- and motor-evoked potentials in predicting and monitoring
the effect of therapy in spondylotic cervical myelopathy. Prospective randomized
study. Spine (Phila Pa 1976). 1999;24(15):1593–8.
9. Kadanka Z, Mares M, Bednarik J, Smrcka V, Krbec M, Chaloupka R, et al.
Predictive factors for spondylotic cervical myelopathy treated conservatively
or surgically. Eur J Neurol. 2005;12(1):55–63.
10. Hu Y, Ding Y, Ruan D, Wong YW, Cheung KMC, Luk KDK. Prognostic value
of somatosensory-evoked potentials in the surgical management of cervical
spondylotic myelopathy. Spine. 2008;33(10):E305–10.
11. Morishita Y, Hida S, Naito M, Matsushima U. Evaluation of cervical spondylotic
myelopathy using somatosensory-evoked potentials. Int Orthop.
2005;29(6):343–6.
12. Bouchard JA, Bohlman HH, Biro C. Intraoperative improvements of
somatosensory evoked potentials: correlation to clinical outcome in surgery
for cervical spondylitic myelopathy. Spine. 1996;21(5):589–94.
13. Ma Y, Hu Y, Valentin N, Geocadin RG, Thakor NV, Jia X. Time jitter of
somatosensory evoked potentials in recovery from hypoxic-ischemic brain
injury. J Neurosci Methods. 2011;201(2):355–60.
14. Nakai S, Sonoo M, Shimizu T. Somatosensory evoked potentials (SEPs) for
the evaluation of cervical spondylotic myelopathy: utility of the onset-latency
parameters. Clin Neurophysiol. 2008;119(10):2396–404.
15. Hu Y, Luk KDK, Lu WW, Leong JCY. Application of time-frequency analysis to
somatosensory evoked potential for intraoperative spinal cord monitoring.
J Neurol Neurosur Ps. 2003;74(1):82–7.
16. Hu Y, Liu HT, Luk KDK. Signal-to-noise ratio of intraoperative tibial nerve
somatosensory-evoked potentials. J Clin Neurophysiol. 2010;27(1):30–3.
17. Yu WR, Liu T, Kiehl TR, Fehlings MG. Human neuropathological and animal
model evidence supporting a role for Fas-mediated apoptosis and inflammation
in cervical spondylotic myelopathy. Brain. 2011;134(Pt 5):1277–92.
18. Nowak J, Hagerman I, Ylen M, Nyquist O, Sylven C. Electrocardiogram signal
variance analysis in the diagnosis of coronary artery disease–a comparison
with exercise stress test in an angiographically documented high
prevalence population. Clin Cardiol. 1993;16(9):671–82.
Cui et al. Journal of NeuroEngineering and Rehabilitation  (2015) 12:49 Page 8 of 819. Liu HT, Xie XB, Xu SP, Wan F, Hu Y. One-unit second-order blind identification
with reference for short transient signals. Inform Sciences. 2013;227:90–101.
20. Hu L, Zhang ZG, Hung YS, Luk KD, Iannetti GD, Hu Y. Single-trial detection
of somatosensory evoked potentials by probabilistic independent component
analysis and wavelet filtering. Clin Neurophysiol. 2011;122(7):1429–39.
21. Liu HT, Chang CQ, Luk KDK, Hu Y. Comparison of blind source separation
methods in fast somatosensory-evoked potential detection. J Clin
Neurophysiol. 2011;28(2):170–7.
22. Kearney RE. Evaluation of the Wiener filter applied to evoked EMG
potentials. Electroencephalogr Clin Neurophysiol. 1979;46(4):475–8.
23. Ting KH, Fung PC, Chang CQ, Chan FH. Automatic correction of artifact
from single-trial event-related potentials by blind source separation using
second order statistics only. Med Eng Phys. 2006;28(8):780–94.
24. Tavy DL, Wagner GL, Keunen RW, Wattendorff AR, Hekster RE, Franssen H.
Transcranial magnetic stimulation in patients with cervical spondylotic
myelopathy: clinical and radiological correlations. Muscle Nerve.
1994;17(2):235–41.
25. Wen CY, Cui JL, Liu HS, Mak KC, Cheung WY, Luk KDK, et al. Is diffusion
anisotropy a biomarker for disease severity and surgical prognosis of
cervical spondylotic myelopathy? Radiology. 2014;270(1):197–204.
26. Hanley JA, Mcneil BJ. The meaning and use of the area under a receiver
operating characteristic (Roc) curve. Radiology. 1982;143(1):29–36.
27. Nakamura M, Fujiyoshi K, Tsuji O, Konomi T, Hosogane N, Watanabe K, et al.
Clinical significance of diffusion tensor tractography as a predictor of
functional recovery after laminoplasty in patients with cervical compressive
myelopathy. J Neurosurg Spine. 2012;17(2):147–52.
28. Holly LT, Moftakhar P, Khoo LT, Shamie AN, Wang JC. Surgical outcomes of
elderly patients with cervical spondylotic myelopathy. Surg Neurol.
2008;69(3):233–40.
29. Suri A, Chabbra RP, Mehta VS, Gaikwad S, Pandey RM. Effect of
intramedullary signal changes on the surgical outcome of patients with
cervical spondylotic myelopathy. Spine J. 2003;3(1):33–45.
30. Hoshiyama M, Kakigi R. New concept for the recovery function of short-latency
somatosensory evoked cortical potentials following median nerve stimulation.
Clin Neurophysiol. 2002;113(4):535–41.
31. Matsukado Y, Yoshida M, Goya T, Shimoji K. Classification of cervical
spondylosis or disc protrusion by preoperative evoked spinal electrogram.
Follow-up study. J Neurosurg. 1976;44(4):435–41.
32. Makeig S, Jung TP, Bell AJ, Ghahremani D, Sejnowski TJ. Blind separation of
auditory event-related brain responses into independent components. Proc
Natl Acad Sci U S A. 1997;94(20):10979–84.
33. Beckmann CF, Smith SM. Probabilistic independent component analysis for
functional magnetic resonance imaging. IEEE Trans Med Imaging.
2004;23(2):137–52.
34. Lin QH, Zheng YR, Yin FL, Liang HL, Calhoun VD. A fast algorithm for one-unit
ICA-R. Inform Sciences. 2007;177(5):1265–75.
35. Tang AC, Sutherland MT, McKinney CJ. Validation of SOBI components from
high-density EEG. Neuroimage. 2005;25(2):539–53.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
